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Reactive oxygen species (ROS) are a group of molecules produced in the cell through metabolism of oxygen. Endogenous ROS
such as hydrogen peroxide (H2O2) have long been recognised as destructive molecules. The well-established roles they have in
the phagosome and genomic instability has led to the characterisation of these molecules as non-speciﬁc agents of destruction.
Interestingly, there is a growing body of literature suggesting a less sinister role for this Jekyll and Hyde molecule. It is now
evident that at lower physiological levels, H2O2 can act as a classical intracellular signalling molecule regulating kinase-driven
pathways. The newly discovered biological functions attributed to ROS include proliferation, migration, anoikis, survival and
autophagy. Furthermore, recent advances in detection and quantiﬁcation of ROS-family members have revealed that the diverse
functionsofROScanbedeterminedbythesubcellularsource,locationanddurationofthesemoleculeswithinthecell.Inlightof
this confounding paradox, we will examine the factors and circumstances that determine whether H2O2 acts in a pro-survival or
deleterious manner.
Cell Death and Disease (2011) 2, e213; doi:10.1038/cddis.2011.96; published online 6 October 2011
Subject Category: Experimental Medicine
Reactiveoxygenspecies (ROS)are a family ofmolecules that
include highly reactive free oxygen radicals (e.g., superoxide
anion [O2 
 ] and the hydroxyl radical [OH
 ]) and the stable
‘diffusable’ non-radical oxidants (e.g., hydrogen peroxide
[H2O2]). H2O2 and superoxide have been the main investiga-
tive foci of ROS biology in recent years, and given the fact that
superoxide is rapidly converted to H2O2 in the cell, we will
concentrateonH2O2astheprincipalROSmember.H2O2was
ﬁrst isolated by The ´nard in 1818 and it was quickly recognised
that high concentrations of H2O2 result in cell injury by
damaging key cellular molecules such as DNA and lipids.
1
Later, elevated levels of ROS became synonymous with
genomic instability prompting cell death or carcinogenesis.
2
Commoner et al.
3 ﬁrst described biological ROS production
in 1954. Nearly a decade later, landmark discoveries
occurred, identifying two major sources of such ROS,
mitochondrial superoxide generation and the phagocytic
respiratory burst. The ﬁrst record of mitochondrial superoxide
generation was reported by Boveris et al.
4 During oxidative
phosphorylation and transfer of energy along the electron
transport chain, 1–5% of electrons escape from complexes
I and III, forming superoxide prematurely in the presence of
oxygen.
5 This process of superoxide generation, termed
electron leak, has been implicated in the pathophysiology of
numerous diseases.
6 Babior, in the 1960s, was among the
ﬁrst to suggest a role for ROS in innate immunity. He
hypothesised that the elevated leukocyte oxygen consump-
tion and the concurrent increase in cellular O2 
  accompany-
ing bacterial phagocytosis was vital to the bactericidal activity
of granulocytes.
7 The rapid increase in the redox status of
neutrophils and macrophages while engulﬁng pathogens
became known as the ‘respiratory burst’. The enzyme
responsible was named gp91phox, now known as NADPH
oxidase-2 (Nox2).
8
In the 1970s, a small collection of studies reported that
exogenously addedH2O2 couldmimic the signalling activityof
insulin.
9 This revelation remained within small free radical
research circles until publications in the 1980s reported that
exogenous H2O2 could also stimulate cell proliferation at
lower concentrations.
10 Subsequent research into the ROS-
generating Nox enzymes revealed the true physiological roles
of endogenous H2O2.
11 Interest inthe Nox family intensiﬁed in
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www.nature.com/cddisthe 90s and 00s. Gene proﬁling of gp91phox; identiﬁcation of
seven Nox isoforms (Nox1–5 and Duox1 and 2) and subunits
(p67phox, p47phox, p40phox, and Rac1/2); and proliﬁc
expression of these enzymes in non-phagocytic cell types
became clear through the work of David Lambeth
12 and
others. It was demonstrated that Nox enzymes have a
fundamental role in numerous physiological processes,
including survival signalling.
Pivotal to this expanding ﬁeld of research was elucidating
the precise mechanism through which H2O2 and other ROS
could modulate signalling pathways. The widely accepted
hypothesis proposed by the Tonks group describes reversible
inhibition of phosphatases that negatively regulate signalling
cascades through oxidation of redox-sensitive cysteine
residues.
13 We now know that ROS have opposing roles in
the cell under speciﬁc conditions. This review will examine
factors such as source and site of H2O2 formation to further
discuss this conﬂicting role of cellular ROS.
Cellular ROS Generation
Nox enzymes, activated by various growth factors and
cytokines, generate H2O2 or O2 
  for signalling processes
such as proliferation, migration and survival.
14 Several other
sources of endogenous ROS exist such as mitochondria,
xanthine oxidase, lipoxygenase and myeloperoxidase.
Notably, they fail to show the diverse physiological functions
attributed to the Nox family, and hence, will not be discussed
further.
Theoriginal hypothesisofNox-mediatedROSgenerationis
based on the gp91phox/Nox2 prototype characterising Nox
proteins as integral membrane proteins (Figure 1). Six
transmembrane domains form a channel to allow successive
transfer of electrons. Electrons are transferred from NADPH
(converting it to NADP
 ) to ﬂavin adenine dinucleotide (FAD)
to haeme and ﬁnally to oxygen to form superoxide.
12
Neutrophil stimulation leads to the assembly of an active
Nox2 complex at the plasma membrane. This complex
comprises a catalytic subunit, the integral membrane protein
gp91phox and a p22phox subunit. Activation of this catalytic
core relies on the recruitment of several cytosolic protein
subunits.
15 This complex then releases O2 
  at micromolar
concentrations into the phagosome, killing the pathogen, a
process known as the respiratory burst.
16 By contrast, little is
known about the assembly/activation of the other Nox-family
members. Cytokines and growth factors induce ROS produc-
tion through activation of locally recruited Noxs in non-
phagocytic cell types.
14 Nox1, 2, 3 and 5 produce O2 
 ,
whereas Duox1 and 2, and more recently Nox4, are known to
produce H2O2 directly because to a peroxidase-like domain at
their N-terminus.
17,18 The consequence of differential produc-
tion of ROS members by Nox enzymes has yet to be
established.
Accurate quantiﬁcation and localisation of H2O2 have been
the rate-limiting factors in ROS cell signalling research. This
stumbling block is further compounded by recent evidence
suggesting that H2O2 is not as freely diffusible as once
thought. Miller et al.
19 demonstrated that aquaporin-3
regulated the transmembrane movement of Nox-derived
H2O2. The most prevalent method of imaging biological
ROS is through use of ﬂuorescent redox-sensitive dyes such
as 20,70-dichloroﬂuorescein diacetate or similar (dihydroethi-
dium, dihydrorhodamine, MitoSox Red and Amplex Red)
(Figure 2). Widely acknowledged reservations exist regarding
speciﬁcity, cell/tissue uptake and subcellular diffusion
dynamics of ﬂuorescent dyes that demand cautious inter-
pretation.
20 Fluorescent probes such as green ﬂuorescent
protein (GFP) and variants (e.g., reduction–oxidation-sensitive
GFP (roGFP) and hydrogen peroxide sensor (HyPER))
incorporate redox-sensitive cysteines, becoming ﬂuorescent
in the presence of particular ROS.
21 The advantages of
ﬂuorescent probes include greater sensitivity and speciﬁcity,
signal reversibility and easy modiﬁcation with targeting
sequences to allow subcellular expression, for example,
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Figure 1 Nox2 structure. Exposure to pathogenic organism triggers Nox2 complex assembly in the neutrophil by recruiting various subunits to the plasma membrane.
The activated Nox complex then releases superoxide in micromolar concentrations into the phagosome, thus killing the pathogen
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22 Further developments include
generation of transgenic animals expressing these redox-
sensitive proteins, thus creating invaluable in vivo models, for
example, zebraﬁsh.
23 Several cell-free assays have been
used to measure O2 
  and H2O2 production as a reﬂection of
Nox activity, yet these methods shed little light on H2O2 as a
second messenger molecule in subcellular domains.
24
We now understand that non-phagocytic Nox enzymes are
no longer conﬁned to the plasma membrane. They have been
identiﬁed in numerous subcellular compartments such as the
endoplasmic reticulum, nucleus and mitochondria.
22,25,26 The
seven Nox isoforms show a complex heterogeneity in which
one or more isoforms may be located in several subcellular
compartments within a single cell type.
27 This expression
proﬁle is echoed by the varied subcellular expression levels of
both antioxidant enzymes and redox-sensitive protein
targets.
28 Indeed expression of Nox enzymes in speciﬁc
subcellular locations can dictate participation in distinct
signalling pathways. Ushio-Fukai
29 published a thorough
review on the compartmentalisation of Noxs affecting immune
signalling pathways. Several papers describing compartmen-
talised H2O2 survival signalling have emerged recently.
30–32
A complex array of enzymatic (i.e., superoxide dismutase,
catalase, thioredoxin and peroxiredoxin (Prx)) and non-
enzymatic (i.e., glutathione; ﬂavonoids; and vitamins A, C
andE)antioxidantsystemsprotectcellsagainstROSdamage
(Table 1). Effective antioxidant activity is necessary to buffer
ﬂuctuations in the cellular redox status and avoid irreversible
oxidation of integral cellular macromolecules such as pro-
teins, lipids and DNA. Recent data have shown that certain
antioxidant members are precisely regulated by Nox-driven
signalling to channel H2O2 to colocalised target proteins.
Toledano et al.
33 examine reversible inactivation through
phosphorylation of Prx1 colocalised to Nox, c-Src and
receptor tyrosine kinases. In consequence to growth factor
and cytokine stimulation, kinase-driven pathways are thought
to bothactivateNox activityandmoreover,phosphorylate and
thus inactivate local Prx1. This process ensures direct,
efﬁcient H2O2 delivery to the target protein.
The intimate relationship that exists between nitric oxide
(NO ), another second messenger molecule, and the ROS
family warrants mention. NO synthases (NOSs) metabolise
arginine to citrulline and generate freely diffusible NO ,a
small diatomic molecule with one unpaired electron. At lower
concentrations,NO  reactswithcertaintargetproteinsmainly
through post-translational S-nitrosylation, thus regulating cell
survival,smoothmuscletoneandimmunesignalling.
34Higher
concentrations of NO  often trigger ‘indirect reactions’
requiring an intermediary reaction with oxygen or O2
  to
produce reactive nitrogen species (RNS). This well-recog-
nised crosstalk with ROS members is known to generate a
spectrum of harmful oxidants comparable to excessive ROS,
including peroxynitrite (ONOO
 ) and nitrogen dioxide (NO2).
This strangely familiar dichotomy, mirroring ROS biology, is
governedbysimilarparameters,including subcellularlocation
and concentration. The double-edged sword nature of NO
reactions is exempliﬁed in the setting of apoptosis. Over-
production of RNS (nitrosative stress), as with oxidative
stress, can potentially trigger cell death processes such as
DNA fragmentation and lipid oxidation.
35 However, RNS can
also have a protective role involving nitrosation of caspases
and PARP, leading to inhibition of apoptosis.
36
Figure 2 Subcellular localisation of Nox-generated H2O2. Multi-photon
microscopy images of Nox-generated ROS in MV411 acute myeloid leukaemia
cells (courtesy of Dr Lavinia Bhatt). The ROS-sensitive dye, Peroxy Orange-1
(PO1), stains red in the presence of ROS. The ﬂuorescence observed shows a
staining pattern consistent with the endoplasmic reticulum
Table 1 Enzymatic antioxidants
Enzymatic antioxidant Cellular location Substrate Reaction
Superoxide dismutase (Mn/Cu/ZnSOD) Mitochondrial matrix (MnSOD)
Cytosol (Cu/ZnSOD)
Superoxide (O2 
 )O 2 
 -H2O2
Catalase Peroxisomes
Cytosol
Hydrogen peroxide (H2O2)2 H 2O2-O2+H2O
Glutathione peroxidase (GPX) Cytosol Hydrogen peroxide (H2O2)H 2O2+GSH-GSSG+H2O
Peroxiredoxin I-VI (Prx) Cytosol Hydrogen peroxide (H2O2)H 2O2+TrxS2-Trx(SH)2+H2O
Superoxide dismutases (SODs) catalyse the breakdown of superoxide into oxygen and H2O2. These enzymes, located in the cytosol and mitochondria, require a
metal ion cofactor, copper (Cu), zinc (Zn) or manganese (Mn). Catalase is localised to the peroxisome, where it converts H2O2 to water and oxygen. Glutathione
peroxidases are a large family of enzymes that reduce H2O2 to water. They are found both in the cytoplasm and extracellularly in almost every human tissue. Prxs
catalyse the reduction of H2O2, organic hydroperoxides as well as peroxynitrite (ONOO
 ). Please note that several non-enzymatic antioxidants exist, including
thioredoxin; vitamin A, C and E; and melatonin. The varied expression proﬁles, subcellular locations and substrates of the above mentioned antioxidant systems
reﬂect the complex nature of ROS biology. It is clear that they are vital to escape oxidative damage and ensure cell survival
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Understanding the mechanism through which H2O2 modu-
lates signalling pathways is paramount to unearthing the
signalling role of Noxs. In keeping with Nox activity, ﬁnely
controlled, modest ﬂuctuations of the cellular redox status
have been shown to be capable of reversible modulation of
signalling cascades. Three principal mechanisms of survival
pathway activation have been proposed: (a) inhibition of
phosphatases, (b) activation of tyrosine kinases and (c)
transcription factor activation (Figure 3).
A large body of evidence identiﬁes cysteine residues as the
most likely targets of Nox-generated ROS. Reversible
oxidation of cysteine residues occurs when sulphenic acid
intermediates (Cys-SOH) are formed. Reversal of this
reaction is mediated by incubation with thiol compounds.
Interestingly, this process of protein reduction is thought to be
equally signiﬁcant as Nox enzymes in the redox regulation of
signalling pathways.
37 Importantly, exposure of the highly
conserved cysteine residue to excessive ROS leads to
irreversible oxidation of the cysteine residue to sulphinic and
sulphonic acid, a process that often accompanies cell death/
injury processes.
38,39 Several signalling pathways are driven
byproteintyrosinekinases(PTKs)throughphosphorylation.
40
By contrast, phosphatases dephosphorylate signalling
proteins, resulting in their inactivation. Phosphatases, a
structurally diverse family of receptor-like non-transmem-
brane enzymes, target speciﬁc substrates in vivo and are
critical regulators of signalling pathways. The phosphatase
super-family includes protein tyrosine phosphatases (PTPs),
dual-speciﬁcity phosphatases (DSPs) and serine/threonine
phosphatases.
14
PTPs, including PTP-1B, SHP1 and SHP2, represent the
most well-described in vivo targets of Nox-mediated H2O2
signalling. The PTP signature motif, HC(X)5R(S/T), creates a
unique environment for the catalytic cysteine residue. The
presence of a conserved arginine residue confers an
unusually low pKa, hence rendering the cysteine residue
highly susceptible to oxidation.
13 Oxidation of the cysteine
residue results in inhibition of activity because the modiﬁed
cysteine can no longer function as a phosphate acceptor.
Colocalisation of Nox4 and PTP-1B at the endoplasmic
reticulum results in enhanced extracellular signal-regulated
(ERK) signalling and proliferation upon reversible cysteine
oxidation.
22 Nox2 activity has been shown to inactivate SHP2
phosphatases thus enhancing erythropoietin (EPO)-induced
STAT5 (signal transducer and activator of transcription-5)
signalling.
41 Oxidative inhibition of DSPs such as phospha-
tase and tensin homologue (PTEN) and cdc25 results in the
formation of a disulphide bond between oxidised cysteines
inactivating phosphatase activity and furthermore preventing
irreversible oxidation.
42 Oxidative inhibition, for example by
Nox1, prevents PTEN-mediated dephosphorylation of lipid
phosphatidylinositol triphosphate-3 (PIP3) to PIP2, allowing
recruitment of PH-containing proteins to the plasma mem-
brane, thus augmenting PI3K/AKT survival signalling.
43 The
Ser/Thr phosphatases (PP1, PP2A, PP2B and PP2C) depho-
sphorylate serine and threonine, which are the main phos-
phorylationsitesinthe transductionof thekinase-driven PI3K/
AKT survival pathway. We demonstrated that BCR-ABL-
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PTEN Src
ROS PP2a
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p53
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Figure 3 Nox regulation of the PI3K/AKT pathway. Activation of Nox activity occurs upon growth factor stimulation. This happens through recruitment of various protein
subunits or by induction of Nox isoform expression. Nox-derived H2O2 then regulates kinase-driven survival signalling, for example, the PI3K/AKT pathway, by three major
mechanisms. The cysteine residues located at the active sites of speciﬁc phosphatases are susceptible to reversible oxidation. This oxidation results in the inhibition of these
phosphatases that negatively regulate survival signalling, thus propagating a pro-survival effect. Nox-generated ROS can also stimulate many pro-survival kinases (Src) and
transcription factors (NF-kB), resulting in enhanced survival signalling
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and consequent upregulation of PI3K/AKT signalling.
44
Evidence also exists for ROS-mediated activation of PTKs
such as Src. For example, upon cell attachment to the
extracellular matrix (ECM) and associated generation of
H2O2, the tyrosine kinase Src becomes oxidised at two
cysteine residues and thus becomes activated.
45 Moreover,
antioxidant treatment of cells that express an oncogenic form
of Src (v-Src), or mutation of v-Src cysteine residues, reduces
the potency of v-Src to transform cells.
46 ROS induction of
gene expression has been extensively investigated. ROS-
mediated expression of tumour necrosis factor-a (TNFa),
transforming growth factor-b1 (TGF-b1), angiotensin and
others occurs by two distinct pathways, either downstream
from signalling pathways described earlier (e.g., MAPK) or
through redox-sensitive transcription factors, (e.g., NF-kB,
hypoxia-inducible factor-1a (HIF-1a), p53 and activator
protein-1 (AP-1)).
14 These transcription factors contain
cysteine residues in their DNA-binding domains thus render-
ing them susceptible to oxidative modulation. It has been
shown that Src-mediated activation of HIF-1a occurs through
Nox-generated ROS and not by direct phosphorylation as
previous thought.
47
H2O2 can modulate enzyme activity by several differing
mechanisms (Figure 3). Identiﬁcation of speciﬁc protein
targets of Nox-mediated ROS is vital to delineating their
ever-expanding roles in cellular signalling pathways.
Growth Factor-Induced ROS Generation
Nox activity increases upon stimulation of the relevant
receptors and regulates many downstream survival signalling
pathways, including PI3K/AKT and MAPK.
48 Signalling
mechanisms coupling growth factor receptor activation to
Nox activity remain largely unknown. Nox activation in non-
phagocytic cell types varies considerably and continuingly
drifts away from the prototypical Nox2 paradigm.
49 Various
triggers result in Nox-mediated H2O2 generation by either (a)
stimulating Nox isoform activity by recruiting or inducing
various Nox regulatory subunits, or (b) by triggering Nox
isoform expression.
Numerous stimuli increase non-phagocytic Nox expres-
sion. Given the large amount of contrasting data, induced
expression of particular Noxs appears to be both stimulus and
cell type-speciﬁc. Nox1 transcription is upregulated by growth
factors receptors (platelet-derived growth factor (PDGF)),
50
inﬂammatory mediators (interferon-g (IFN-g)), pathogenic
molecules (lipopolysaccharide (LPS)), vitamin D3 and hypox-
ia (HIF-1a). GATA-6 and STAT1 have both been implicated in
the transcriptional regulation of Nox1.
51 Nox4 expression
occurs in a plethora of cell types, including pancreatic,
vascular smooth muscle (VSMC) and myeloid cell lines.
49
Activators of Nox4 transcription in smooth muscle cells
include urokinase, plasminogen activator, angiotensin-II,
TGF-b1 and TNF-a.
51 Currently, there are little data regarding
Nox4-related transcription factors and promoter structures.
Duox1 and Duox2 are widely and differentially expressed
throughout most human tissues. Induction of Duox1 and
Duox2 expression has been elicited in response to Th1
and Th2 dominant cytokines, respectively.
52 Interestingly,
regulation of Duox expression in animal models by pathways
such as cAMP have failed to correlate with human cell lines/
tissues.
53 Despite studies identifying Duox promoter regions,
a void remains pinpointing relevant transcription factors.
Expression of Nox3 and Nox5 has been documented in
various human tissues; however, characterisation of speciﬁc
promoter regions and transcription factors remains
unchecked.
Upregulation of Nox activity accounts for growth factor-
induced ROS production in most cases of Nox pro-survival
signalling. Nox1 and Nox3 tend to follow the original Nox2
model such that a stimulus triggers the formation of the active
Nox complex, coupled with various combinations of protein
subunits. These activating cytoplasmic proteins include
p22phox, p47phox and homologue NoxO1, p67phox and
homologue NoxA1, and Rac1/2.
12 Activation of these sub-
units appears to rely heavily on phosphorylation by speciﬁc
kinases. A resultant increase in Nox activity in response to
subunit phosphorylation has only been demonstrated in the
case of p47phox and Rac. Phosphorylation of p47phox by
speciﬁc kinases (protein kinase-C (PKC), p38 MAPK,
p21-activated kinase), removes its inherent auto-inhibition,
allowing p47phox to bind to the cytoplasmic tail of p22phox,
activating the Nox complex.
54 Rac1/2 is a small RhoGTPase
and can be bound to GDP, making it inactive, or to GTP,
making it active. Guanine nucleotide exchange factors
(GEFs) and guanine-activating proteins (GAPs) promote
andinhibitRac1/2binding,respectively.
14Nearly200different
GAPs and GEFs have been identiﬁed thus reﬂecting the
complexity of potential Nox activation mechanisms in Rac-
dependentNox1&2alone.p22phoxisknowntoassociatewith
Nox4; however, whether it is required for ROS generation is
uncertain. A novel p22phox-interacting protein, poldip2, has
recently been shown to activate Nox4 in VSMC lines.
55 By
contrast, some groups claim that Nox4 is constitutively active
andregulatedbyexpressionalone.
56Nox5,Duox1andDuox2
are activated by increased calcium concentrations, owing to
EF-hand Ca
2þ-binding domains. It has been shown that
calcium binding triggers a conformational change at the
N-terminal, thus permitting transfer of electrons.
57 Jagnandan
et al.
58 showed that phorbol-12-myristate-13-acetate (PMA)-
induced ROS led to the phosphorylation of Nox5, increasing
sensitivity to calcium, promoting activation at lower calcium
concentrations. Although recent papers describe Nox5
regulation by PKA, PKC, PIP2 and c-Abl, activation of Nox5
by factors other than calcium remains unclear.
59 Similar to
Nox4 activation, the necessity for Duox–p22phox binding is of
uncertain consequence.
60
The novel growth factor receptor–Nox relationship con-
tinues to show exquisite heterogeneity, currently masking any
potential mechanism that may transcend the spectrum of
stimuli and Nox isoforms described.
Nox Disease Links
The link between Nox activity and the pathogenesis of acute
and chronic diseases has been well-described.
61 Cancerous
cells have been frequently associated with overproduction of
ROS accountedforbyelevated expressionand activityof Nox
enzymes downstream from constitutively active growth factor
H2O2: pro-survival or deleterious activity?
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62 Nox enzymes are inherent to processes synon-
ymous with tumour phenotypes such as enhanced survival
signalling, proliferation, angiogenesis and metastasis owing
to a novel oncogene–Nox relationship.
63–65
Several oncogenes and constitutively active growth factor
receptors are known to upregulate both Nox activity and
expression, including Ras, Flt3 and BCR-ABL, by mechan-
isms described in the previous section. Jung et al. demon-
strated the oncogenic effect of translationally controlled
tumour protein (TCTP) in breast cancer cells. Augmented
Noxactivity/expressioncorrelatedwithupregulatedepidermal
growth factor receptor (EGFR), PI3K/AKT, ERK activity and
matrix metalloproteinase expression.
66 This exempliﬁes not
only the unique oncogene–Nox relationship, but also the
many Nox-driven processes underlying tumour progression.
Upregulation of Nox1 and increased Nox1 mRNA levels have
been shown to correlate well with oncogenic mutations in
K-Ras.
67 FLT3-ITD receptors maintain Nox signalling by
phosphorylating STAT5, which colocalises to Rac1, thus
regulating the activity of Nox1 and Nox2.
68
The setting of elevated ROS production, termed oxidative
stress, has long been known to promote genomic instability,
augmenting favourable growth mutations and chemoresis-
tance.
69 Nox2 activity-induced genomic instability was
responsible for the tumour-promoting mechanism of the
oncogenic Epstein–Barr virus (EBV) nuclear antigen
(EBNA)-1.
70 The recognised internal tandem duplication
mutation of the FLT3 receptor (FLT3-ITD) augmented
Nox-generated ROS, leading to elevated double-stranded
DNA break frequency.
68 Slupianek et al.
71 highlighted a
bimodal mutagenic effect of BCR-ABL through induction of
Nox-mediated DNA damage coupled with dysregulation of
DNA-repair mechanisms by Werner protein gene (WRN)
activation. Clearly, Nox-generated ROS under certain condi-
tions can potentially promote genomic instability irrespective
of their intended protein targets.
Several tumour cell types also demonstrate increased
antioxidant capacity correlating well with oxidative stress,
suggesting that enhanced antioxidant activity is necessary for
tumour progression. H-Ras-transformed cells, known to
produce high levels of ROS, also expressed elevated levels
of Prx1 and thioredoxin peroxidase when compared with their
benign parental cells.
72 In melanoma cells, pro-survival c-Myc
was shown to upregulate GSH, conferring survival beneﬁt.
73
Interestingly, this adaptive upregulation of antioxidant
enzymes is also known to confer chemoresistance to cancer
cells when exposed to certain chemotherapeutic drug
classes, for example, taxanes.
74
Given the exaggerated nature of tumour cell survival
pathways, the majority of studies describing pro-survival
Nox signalling involve cancer cell types. Mochizuki et al.
75
showed that Nox4 activated the AKT/ASK1 pathway in
pancreatic PANC1 tumour cells. Nox4 also has a role in
NF-kB survival signalling in melanoma cells.
76 Ras is known
topromoteinvasionandmetastasisthroughauniquepathway
in which leukotriene-B4 receptor-2 (BLT2) stimulated Nox1,
activating NF-kB and leading to a subsequent upregulation of
matrix metalloproteinase-9.
77
While most literature implicating Nox survival signalling
appearsto lackcoherency,its roleinprotectionfrom anoikis is
well elucidated. Anoikis is the apoptotic process induced by
loss of contact with the ECM observed typically in non-
transformed adherent cells. Integrin activation through ECM–
cell contact stimulates Rac1-dependent intracellular ROS
production during cell spreading.
78 The proposed target of the
ROS, the tyrosine kinase, Src, participates in the crosstalk
between ECM contact and the propagation of survival
signalling. Oxidised Src then promotes ligand-independent
phosphorylation and activation of EGFR. Downstream signal-
ling through ERK and Akt pathways results in the phosphor-
ylation and degradation of the pro-apoptotic protein Bim, thus
escaping apoptosis.
79 It was recently demonstrated that
angiopoietin-related protein-4 (ANGPTL4)-stimulated Nox1
activity can mimic anchorage-dependent growth conditions in
tumour cells, thus aiding metastasis.
80
Nox enzymes can have two distinct roles with regard to
oncogene-driven tumour promotion. It is likely that genomic
instability in the setting of increased Nox activity exists as an
off-target effect. The subcellular localisation, and particularly,
theproximitytothe nucleusofthe relevantNoxenzymes,may
hold the answer to this bimodal pro-survival effect.
Future Perspectives
ItisclearthatNox-generatedH2O2canhaveopposingrolesin
the cell owing to its novel second messenger status. The
initiation and propagation of pro-survival signalling in
response to ROS relies heavily on subcellular location of
Nox enzymes as well as on stimulus and cell type. Several
mechanisms exist through which ROS can potentially
modulate signalling by oxidation. Importantly, several aspects
ofROSsignallingremainuncertain.Theuncertaintyregarding
intracellular H2O2 diffusion dynamics demands clariﬁcation.
The recent aquaporin-3 data coupled with the exquisite
speciﬁcity of ROS signalling explicitly contradict the widely,
and perhaps blindly, accepted ‘freely diffusible’ theory of
H2O2. Furthermore, identiﬁcation of speciﬁc ROS protein
targets together with compartmentalisation of Nox activity will
uncover the unique mechanisms by which Noxs regulate
various cellular signalling pathways. Finally, enormous
potential exists for therapeutic manipulation of the Nox-driven
mechanisms of tumour promotion described earlier. In light of
the disappointing performance of antioxidants in the clinical
chemotherapeutic arena, targeted Nox isoform inhibition
represents a novel anticancer strategy in the future.
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